Concepedia

Author

David J. Inwards

Mayo ClinicORCID

Also Known As

D Inwards, D J Inwards, D. Inwards, D. J Inwards, D. J. Inwards, D.J. Inwards, David Inwards, David J Inwards, David J. Inwards, David James Inwards

443

Publications

15.3K

Citations

69

H-Index

115

Concepts

All Affiliations

Mayo ClinicMayo Clinic in ArizonaMayo Clinic in FloridaMedical College of WisconsinWinnMed
DJ

About

David J. Inwards is an author at Mayo Clinic specializing in medicine, immunology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

42

88

5.1K

2

Health Sciences

20

31

1.1K

3

Public Health

3

3

350

4

Education

1

1

17

5

Engineering

1

1

14

David J. Inwards

×

188

Publications

13.7K

Citations

66

H-Index

YearCitations

Phase II Trial of Single-Agent Temsirolimus (CCI-779) for Relapsed Mantle Cell Lymphoma

Thomas E. Witzig, Susan M. Geyer, Irene M. Ghobrial,

Journal of Clinical Oncology

2005

520

Lenalidomide Combined With R-CHOP Overcomes Negative Prognostic Impact of Non–Germinal Center B-Cell Phenotype in Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Phase II Study

Grzegorz S. Nowakowski, Betsy LaPlant, William R. Macon,

Journal of Clinical Oncology

2014

362

Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma

Stephen M. Ansell, Sara A. Hurvitz, Patricia Koenig,

Clinical Cancer Research

2009

330

Rates and Outcomes of Follicular Lymphoma Transformation in the Immunochemotherapy Era: A Report From the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource

Brian K. Link, Matthew J. Maurer, Grzegorz S. Nowakowski,

Journal of Clinical Oncology

2013

326

Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Angela Dispenzieri, Morie A. Gertz, Robert A. Kyle,

Blood

2004

318

Early lymphocyte recovery predicts superior survival after autologous hematopoietic stem cell transplantation in multiple myeloma or non-Hodgkin lymphoma

Luis F. Porrata, Morie A. Gertz, David J. Inwards,

Blood

2001

266

Absolute values of immunoglobulin free light chains are prognostic in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation

Angela Dispenzieri, Martha Q. Lacy, Jerry A. Katzmann,

Blood

2006

250

Superior survival in primary systemic amyloidosis patients undergoing peripheral blood stem cell transplantation: a case-control study

Angela Dispenzieri, Robert A. Kyle, Martha Q. Lacy,

Blood

2004

241

Hematopoietic Cell Transplantation for Systemic Mature T-Cell Non-Hodgkin Lymphoma

Sonali M. Smith, Linda J. Burns, Koen van Besien,

Journal of Clinical Oncology

2013

229

A Phase II trial of the oral mTOR inhibitor everolimus in relapsed Hodgkin lymphoma

Patrick B. Johnston, David J. Inwards, Joseph P. Colgan,

American Journal of Hematology

2010

219

Page 1